Infinity Pharmaceuticals Stock

Infinity Pharmaceuticals P/CF

P/CF (Price-to-Cash-Flow Ratio) of Infinity Pharmaceuticals (INFIQ) as of Aug 4, 2026.

P/CF

-0.00

YoY

-4.27%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Infinity Pharmaceuticals is 2026 -0.00 . P/CF (Price-to-Cash-Flow Ratio) of Infinity Pharmaceuticals was 2025 -0.00 . It decreases by -4.27% higher compared to the previous year.
Access this data via the Eulerpool API

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals